Previous Close | 2.7900 |
Open | 2.6500 |
Bid | 2.7000 x 36200 |
Ask | 2.7700 x 41800 |
Day's Range | 2.6500 - 2.8800 |
52 Week Range | 1.9500 - 28.8500 |
Volume | |
Avg. Volume | 12,611,218 |
Market Cap | 1.288B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.4230 |
Earnings Date | Aug 09, 2022 - Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for CLOV
Every investor in Clover Health Investments, Corp. ( NASDAQ:CLOV ) should be aware of the most powerful shareholder...
Clover Health Investments’ (NASDAQ:CLOV) earnings continue being negative although some operating numbers seem to offer hope of a better stock price in the future for CLOV stock. For instance, in February the company announced that its 2022 revenues were expected to be more than $3 billion; this would be largely thanks to a forecast 90% yearly growth in the number of lives under management. Considering that the company reported that there was an increase of almost 300% year over year in the numb
First quarter total revenue was $874.4 million, compared to $200.3 million in first quarter 2021 Lives under Clover Management grew to ~257,000 from ~66,000 year-over-year First quarter Insurance (Medicare Advantage) Medical Care Ratio (MCR) of 96.4% and Non-Insurance (Direct Contracting) MCR of 99.8% show significant improvement quarter-over-quarter Full-year 2022 revenue expected to be $3.0 billion to $3.4 billion Clover continues to expect 2022 Insurance MCR of 95% to 99% and a further step-w